Stockreport

REGENXBIO receives Fast Track designation for RGX-111 gene therapy for the treatment of MPS I [Seeking Alpha]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF REGENXBIO receives Fast Track designation for RGX-111 gene therapy for the treatment of MPS IFDAgrants Fast Track designation for REGENXBIO's (NASDAQ:RGNX) RGX-111. RGX- [Read more]